These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18476957)

  • 1. A phase II dose-ranging study of topical resiquimod to treat actinic keratosis.
    Szeimies RM; Bichel J; Ortonne JP; Stockfleth E; Lee J; Meng TC
    Br J Dermatol; 2008 Jul; 159(1):205-10. PubMed ID: 18476957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze).
    Nelson C; Rigel D; Smith S; Swanson N; Wolf J
    J Drugs Dermatol; 2004; 3(4):401-7. PubMed ID: 15303784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses.
    Ulrich C; Johannsen A; Röwert-Huber J; Ulrich M; Sterry W; Stockfleth E
    Eur J Dermatol; 2010; 20(4):482-8. PubMed ID: 20507841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials.
    Korman N; Moy R; Ling M; Matheson R; Smith S; McKane S; Lee JH
    Arch Dermatol; 2005 Apr; 141(4):467-73. PubMed ID: 15837864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of multiple actinic keratoses with topical diclofenac 3% gel in organ transplant recipients: a series of six cases.
    Ulrich C; Hackethal M; Ulrich M; Howorka A; Forschner T; Sterry W; Stockfleth E
    Br J Dermatol; 2007 May; 156 Suppl 3():40-2. PubMed ID: 17488405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis.
    Anderson L; Schmieder GJ; Werschler WP; Tschen EH; Ling MR; Stough DB; Katsamas J
    J Am Acad Dermatol; 2009 Jun; 60(6):934-43. PubMed ID: 19467365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial.
    Jorizzo J; Weiss J; Furst K; VandePol C; Levy SF
    Arch Dermatol; 2004 Jul; 140(7):813-6. PubMed ID: 15262691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical resiquimod dosing regimens in patients with multiple actinic keratoses: a multicentre, partly placebo-controlled, double-blind clinical trial.
    Stockfleth E; Hofbauer GFL; Reinhold U; Popp G; Hengge UR; Szeimies RM; Brüning H; Anliker M; Hunger T; Dummer R; Ulrich C; Kenzelmann R; Surber C; French LE
    Br J Dermatol; 2019 Feb; 180(2):297-305. PubMed ID: 30171698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial.
    Mark KE; Corey L; Meng TC; Magaret AS; Huang ML; Selke S; Slade HB; Tyring SK; Warren T; Sacks SL; Leone P; Bergland VA; Wald A
    J Infect Dis; 2007 May; 195(9):1324-31. PubMed ID: 17397003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ingenol mebutate gel for actinic keratosis.
    Lebwohl M; Swanson N; Anderson LL; Melgaard A; Xu Z; Berman B
    N Engl J Med; 2012 Mar; 366(11):1010-9. PubMed ID: 22417254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study.
    Siller G; Gebauer K; Welburn P; Katsamas J; Ogbourne SM
    Australas J Dermatol; 2009 Feb; 50(1):16-22. PubMed ID: 19178487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective photodynamic therapy of actinic keratoses on the head and face with a novel, self-adhesive 5-aminolaevulinic acid patch.
    Hauschild A; Popp G; Stockfleth E; Meyer KG; Imberger D; Mohr P; Itschert G; Kaufmann R; Neuber K; Frambach Y; Gollnick H; Brunnert M; Stocker M; Ortland C; Karrer S
    Exp Dermatol; 2009 Feb; 18(2):116-21. PubMed ID: 18643849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of actinic cheilitis using diclofenac 3% gel: a report of six cases.
    Ulrich C; Forschner T; Ulrich M; Stockfleth E; Sterry W; Termeer C
    Br J Dermatol; 2007 May; 156 Suppl 3():43-6. PubMed ID: 17488406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of topical 5% 5-fluorouracil (Efudix cream) in the treatment of actinic keratoses comparing daily with weekly treatment.
    Jury CS; Ramraka-Jones VS; Gudi V; Herd RM
    Br J Dermatol; 2005 Oct; 153(4):808-10. PubMed ID: 16181465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diclofenac sodium 3% gel in the treatment of actinic keratoses postcryosurgery.
    Berlin JM; Rigel DS
    J Drugs Dermatol; 2008 Jul; 7(7):669-73. PubMed ID: 18664159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-week treatment with 0.5% fluorouracil cream prior to cryosurgery in patients with actinic keratoses: a double-blind, vehicle-controlled, long-term study.
    Jorizzo J; Weiss J; Vamvakias G
    J Drugs Dermatol; 2006 Feb; 5(2):133-9. PubMed ID: 16485881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of the use of cryosurgery for the treatment of actinic keratoses.
    Thai KE; Fergin P; Freeman M; Vinciullo C; Francis D; Spelman L; Murrell D; Anderson C; Weightman W; Reid C; Watson A; Foley P
    Int J Dermatol; 2004 Sep; 43(9):687-92. PubMed ID: 15357755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical 3.0% diclofenac in 2.5% hyaluronic acid gel induces regression of cancerous transformation in actinic keratoses.
    Dirschka T; Bierhoff E; Pflugfelder A; Garbe C
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):258-63. PubMed ID: 19709346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facial resurfacing for nonmelanoma skin cancer prophylaxis.
    Hantash BM; Stewart DB; Cooper ZA; Rehmus WE; Koch RJ; Swetter SM
    Arch Dermatol; 2006 Aug; 142(8):976-82. PubMed ID: 16924046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities.
    Kaufmann R; Spelman L; Weightman W; Reifenberger J; Szeimies RM; Verhaeghe E; Kerrouche N; Sorba V; Villemagne H; Rhodes LE
    Br J Dermatol; 2008 May; 158(5):994-9. PubMed ID: 18341663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.